The usual Ocrevus dosage for multiple sclerosis (MS) and clinically isolated syndrome is two starting infusions given 2 weeks apart, and then an infusion every 6 months. Ocrevus (ocrelizumab ...

Multiple sclerosis is a chronic condition affecting ... approved the first DMT for people with PPMS. This infusion drug, ocrelizumab (Ocrevus), can also be used to treat RRMS.

The Multiple Sclerosis Treatment Optimization Program (MSTOP) was motivated by research showing that Black and Hispanic ...

Levels of B-cells can help to predict the risk of disability progression independent of relapse activity in relapsing MS ...

According to the National Multiple Sclerosis Society (NMSS), MS is a chronic autoimmune disease that affects the central ...

With the right strategies, you can ‘treat the treatment’ and use your MS medications reliably and successfully.

According to the U of A's Multiple Sclerosis Center ... the most effective drugs were often delivered by infusion, which meant regular trips to a big city to get treatment.